Mast cell proteases as pharmacological targets
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Mast cells are rich in proteases, which are the major proteins of intracellular granules and are released with histamine and heparin by activated cells. Most of these proteases are active in the granule as well outside of the mast cell when secreted, and can cleave targets near degranulating mast cells and in adjoining tissue compartments. Some proteases released from mast cells reach the bloodstream and may have far-reaching actions. In terms of relative amounts, the major mast cell proteases include the tryptases, chymases, cathepsin G, carboxypeptidase A3, dipeptidylpeptidase I/cathepsin C, and cathepsins L and S. Some mast cells also produce granzyme B, plasminogen activators, and matrix metalloproteinases. Tryptases and chymases are almost entirely mast cell-specific, whereas other proteases, such as cathepsins G, C, and L are expressed by a variety of inflammatory cells. Carboxypeptidase A3 expression is a property shared by basophils and mast cells. Other proteases, such as mastins, are largely basophil-specific, although human basophils are protease-deficient compared with their murine counterparts. The major classes of mast cell proteases have been targeted for development of therapeutic inhibitors. Also, a human β-tryptase has been proposed as a potential drug itself, to inactivate of snake venins. Diseases linked to mast cell proteases include allergic diseases, such as asthma, eczema, and anaphylaxis, but also include non-allergic diseases such inflammatory bowel disease, autoimmune arthritis, atherosclerosis, aortic aneurysms, hypertension, myocardial infarction, heart failure, pulmonary hypertension and scarring diseases of lungs and other organs. In some cases, studies performed in mouse models suggest protective or homeostatic roles for specific proteases (or groups of proteases) in infections by bacteria, worms and other parasites, and even in allergic inflammation. At the same time, a clearer picture has emerged of differences in the properties and patterns of expression of proteases expressed in human mast cell subsets, and in humans versus other mammals. These considerations are influencing prioritization of specific protease targets for therapeutic inhibition, as well as options of pre-clinical models, disease indications, and choice of topical versus systemic routes of inhibitor administration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tjäderhane, L., Buzalaf, M. A. R., Carrilho, M., & Chaussain, C. (2015) · Caries Research · doi:10.1159/000363582 · Cited by 2,306
Cysteine cathepsins: From structure, function and regulation to new frontiers
Turk, V., Stoka, V., Vasiljeva, O., Renko, M., Sun, T., Turk, B., & Turk, D. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.10.002 · Cited by 1,377 · cited 1×
“As a potential assist to structure-based design of inhibitors, crystal-derived structures of cathepsin C, reveal a tetramer with restricted active sites compared to related cysteine cathepsins (Turk et al., 2001; Turk et al., 2012).”
BackgroundInflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946 · cited 1×
“…Waern et al., 2009) Envenomation (protective) (Akahoshi et al., 2011) Intestinal parasitosis (protective) (Knight et al., 2000) Skin malignancy (Coussens et al., 1999) Aortic aneurysm (Furubayashi et al., 2008; Inoue et al., 2009; Sun et al., 2009) Carboxypeptidase A3 Envenomation (protective)…”
Self-citationTryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
Schwartz, L. B., Metcalfe, D. D., Miller, J. S., Earl, H., & Sullivan, T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162603 · Cited by 784 · cited 1×
“What is clear is that immunoreactive tryptase appears in the bloodstream after major mast cell activation events, such as bee-sting anaphylaxis (Schwartz et al., 1987; Schwartz et al., 1989).”
BackgroundValent, P., Akin, C., Arock, M., Brockow, K., Butterfield, J. H., Carter, M. C., Castells, M., Escribano, L., Hartmann, K., Lieberman, P., et al. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000328760 · Cited by 654
Role for protease activity in visceral pain in irritable bowel syndrome
Cenac, N., Andrews, C. N., Holzhausen, M., Chapman, K., Cottrell, G., Andrade-Gordon, P., Steinhoff, M., Barbara, G., Beck, P., Bunnett, N. W., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29255 · Cited by 591 · cited 2×
“, 2006); visceral pain (Cenac et al., 2007), aortic aneurysms (Zhang et al.”
BackgroundDiagnostic Value of Tryptase in Anaphylaxis and Mastocytosis
Schwartz, L. B. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.05.010 · Cited by 477 · cited 3×
“…cell and basophil proteases (Cairns, 2005; Caughey, 2007, 2011; Douaiher et al., 2014; Hallgren and Pejler, 2006; Harvima et al., 2014; Hellman and Thorpe, 2014; Pejler et al., 2010; Schwartz, 2006; Stevens and Adachi, 2007; Tojo and Urata, 2013; Trivedi and Caughey, 2010; Valent et al., 2012).”
BackgroundSchwartz, L. B., Yunginger, J. W., Miller, J., Bokhari, R., & Dull, D. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114051 · Cited by 456 · cited 1×
“What is clear is that immunoreactive tryptase appears in the bloodstream after major mast cell activation events, such as bee-sting anaphylaxis (Schwartz et al., 1987; Schwartz et al., 1989).”
BackgroundMast cell tryptases and chymases in inflammation and host defense.
Caughey, G. H. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00509.x · Cited by 442 · cited 4×
“potency—Earlier efforts to develop selective inhibitors of soluble mast cell tryptases were reviewed previously (Cairns, 2005; Caughey, 2007, 2011).”
BackgroundInfluentialSelf-citationMast Cell Tryptase Controls Paracellular Permeability of the Intestine
Jacob, C., Yang, P.-C., Darmoul, D., Amadesi, S., Saito, T., Cottrell, G. S., Coelho, A.-M., Singh, P., Grady, E. F., Perdue, M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506338200 · Cited by 334 · cited 2×
“…cigarette smoke-induced COPD (Beckett et al., 2013), itch (Ui et al., 2006); visceral pain (Cenac et al., 2007), aortic aneurysms (Zhang et al., 2011), colitis (Corvera et al., 1997; Hamilton et al., 2010; Jacob et al., 2005), and inflammatory arthritis (McNeil et al., 2008; Shin et al., 2009).”
Background
Cited by
Cellular and molecular mechanisms of asthma and COPD
Barnes, P. J. (2017) · Clinical Science · doi:10.1042/cs20160487 · Cited by 511
IL33: Roles in Allergic Inflammation and Therapeutic Perspectives
Chan, B. C. L., Lam, C. W. K., Tam, L.-S., & Wong, C. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00364 · Cited by 285
Selected recent advances in understanding the role of human mast cells in health and disease
Levi-Schaffer, F., Gibbs, B. F., Hallgren, J., Pucillo, C., Redegeld, F., Siebenhaar, F., Vitte, J., Mezouar, S., Michel, M., Puzzovio, P. G., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.01.030 · Cited by 51
Serum tryptase concentration and progression to end‐stage renal disease
Jesky, M. D., Stringer, S. J., Fenton, A., Ng, K. P., Yadav, P., Ndumbo, M., McCann, K., Plant, T., Dasgupta, I., Harding, S. J., et al. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12622 · Cited by 26
New Biomarkers in Anaphylaxis (Beyond Tryptase)
Galvan-Blasco, P., Gil-Serrano, J., & Sala-Cunill, A. (2022) · Current Treatment Options in Allergy · doi:10.1007/s40521-022-00326-1 · Cited by 19
Metadata
- Authors
- Caughey, G. H.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 778
- Pages
- 44-55
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W582046237
- Cited by
- 150
- References
- 16
- FWCI
- 6.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mast cell proteases as pharmacological targets. https://app.cochat.ai/papers/10.1016/j.ejphar.2015.04.045
- The paper
- Caughey, G. H. (2016). Mast cell proteases as pharmacological targets. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2015.04.045
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.